Concepedia

Gustav Gammelgård

GG

Statistics

Publications

3

Citations

292

H-Index

3

Active since

2018

Affiliations

Uppsala University(Current)

Science for Life Laboratory

Antaros Medical (Sweden)

Karolinska University Hospital

Gustav Gammelgård is an author at Uppsala University specializing in chimeric antigen receptor t-cell therapy, car t cell trials, and immunotherapy.

ORCID

Publications per year

2018–2023

3

Publications

3

A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia

Gunilla Enblad, Hannah Karlsson, Gustav Gammelgård et al. · Clinical Cancer Research · 2018 · 261 citations

, , +17

Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma Patients

Tina Sarén, Mohanraj Ramachandran, Gustav Gammelgård et al. · Clinical Cancer Research · 2023 · 16 citations · Full text

, , +15

Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy

Therese Sjöholm, Alexander Korenyushkin, Gustav Gammelgård et al. · Cancer Imaging · 2022 · 15 citations · Full text

, , +17

1–3 of 3